Creso & Halucenex Might Do Something But According To This Press Release It Could Well be Nothing

Here’s their intro and key points for the ASX which reads like……. I might go to school today but I’ll see whether my best friend is there and get him/her to finish off our assignment on volcanoes.

 

Halucenex Life Sciences Inc. to progress US market entry strategy for botanical psilocybin products and compounds Highlights:

• Consultancy agreement with HeteroGeneity, LLC to assist with US expansion for Halucenex’s botanical psilocybin products

• HeteroGeneity is a leading consultancy focused on assisting companies achieve regulatory approval for new drug developments for use in the USA

• Both parties to collaborate on requirements for potential US market launch

• Defined strategy will allow Halucenex to pursue FDA approval for botanical psilocybin products and commence licencing discussions with large pharma

• Agreement adds to leading partners Halucenex has assembled ahead of its phase II clinical trial – providing considerable competitive advantage

• • US psychedelic drug market expected to total US$6.8Bn by 2027i – highlights a significant opportunity for Creso Pharma

 

Full Press Release

6A1034321_CPH

Primary Sponsor

Top Marijuana Blog